Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins

(1) Background: The aim of this study was to produce in-house ELISAs which can be used to determine SARS-CoV-2-specific antibody levels directed against the spike protein (S), the S1 subunit of S and the receptor binding domain (RBD) of S in SARS-CoV-2 vaccinated and infected humans. (2) Methods: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Aysun, Turan, Nuri, Kocazeybek, Bekir Sami, Dinc, Harika Oyku, Tali, Hasan Emre, Aydin, Ozge, Tali, Hamid Besim, Yilmaz, Semaha Gul, Konukoglu, Dildar, Borekci, Sermin, Bold, Dashzeveg, Roman Sosa, Gleyder, Gungordu, Nejdiye, Vardaloglu, Ilgim, Gareayaghi, Nesrin, Guzel, Mine, Guner, Ebru, Sadeyen, Jean-Remy, Chang, Pengxiang, Iqbal, Munir, Richt, Juergen A., Yilmaz, Huseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777145/
https://www.ncbi.nlm.nih.gov/pubmed/36553092
http://dx.doi.org/10.3390/diagnostics12123085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777145/
https://www.ncbi.nlm.nih.gov/pubmed/36553092
http://dx.doi.org/10.3390/diagnostics12123085

Ejemplares similares